EPIC-Norfolk Publications Database

C-Reactive Protein Identifies Low-Risk Metabolically Healthy Obese Persons: The European Prospective Investigation of Cancer-Norfolk Prospective Population Study.

van Wijk DF, Boekholdt SM, Arsenault BJ, Ahmadi-Abhari S, Wareham NJ, Stroes ES, and Khaw KT

Journal of the American Heart Association. Jun 2016

(DOI : 10.1161/JAHA.115.002823)

C-reactive protein, fatal and nonfatal coronary artery disease, stroke, and peripheral artery disease in the prospective EPIC-Norfolk cohort study.

van Wijk DF, Boekholdt SM, Wareham NJ, Ahmadi-Abhari S, Kastelein JJ, Stroes ES, and Khaw KT

Arteriosclerosis, thrombosis, and vascular biology. Sep 2013

(DOI : 10.1161/ATVBAHA.113.301736)

Chemokine ligand 2 genetic variants, serum monocyte chemoattractant protein-1 levels, and the risk of coronary artery disease.

van Wijk DF, van Leuven SI, Sandhu MS, Tanck MW, Hutten BA, Wareham NJ, Kastelein JJ, Stroes ES, Khaw KT, and Boekholdt SM

Arteriosclerosis, thrombosis, and vascular biology. May 2010

(DOI : 10.1161/ATVBAHA.110.205526)